BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 11127262)

  • 21. Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis.
    Yeaman SJ; Kirby JA; Jones DE
    Immunol Rev; 2000 Apr; 174():238-49. PubMed ID: 10807520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis].
    Xiao H; Chen JW; Xie X; Liu YM; Li F
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):209-14. PubMed ID: 22516989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a lipoyl domain-independent B-cell autoepitope on the human branched-chain acyltransferase in primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis.
    Csepregi A; Obermayer-Straub P; Kneip S; Kayser A; Loges S; Schmidt E; Nemesánszky E; Szalay F; Manns MP; Strassburg CP
    Clin Dev Immunol; 2003; 10(2-4):173-81. PubMed ID: 14768949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary biliary cirrhosis. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1 alpha, a non-lipoic acid containing mitochondrial enzyme.
    Fregeau DR; Roche TE; Davis PA; Coppel R; Gershwin ME
    J Immunol; 1990 Mar; 144(5):1671-6. PubMed ID: 2106552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.
    Dubel L; Tanaka A; Leung PS; Van de Water J; Coppel R; Roche T; Johanet C; Motokawa Y; Ansari A; Gershwin ME
    Hepatology; 1999 Apr; 29(4):1013-8. PubMed ID: 10094940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis.
    Tsuneyama K; Van De Water J; Van Thiel D; Coppel R; Ruebner B; Nakanuma Y; Dickson ER; Gershwin ME
    Hepatology; 1995 Nov; 22(5):1440-6. PubMed ID: 7590661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
    Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C
    Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis.
    Masuda J; Omagar K; Miyakawa H; Hazama H; Ohba K; Kinoshita H; Matsuo I; Isomoto H; Murata I; Kohno S
    Autoimmunity; 2002 Mar; 35(2):135-41. PubMed ID: 12071436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope.
    Leung PS; Chuang DT; Wynn RM; Cha S; Danner DJ; Ansari A; Coppel RL; Gershwin ME
    Hepatology; 1995 Aug; 22(2):505-13. PubMed ID: 7543435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.
    Moteki S; Leung PS; Dickson ER; Van Thiel DH; Galperin C; Buch T; Alarcon-Segovia D; Kershenobich D; Kawano K; Coppel RL
    Hepatology; 1996 Mar; 23(3):436-44. PubMed ID: 8617422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis.
    Shimoda S; Nakamura M; Ishibashi H; Kawano A; Kamihira T; Sakamoto N; Matsushita S; Tanaka A; Worman HJ; Gershwin ME; Harada M
    Gastroenterology; 2003 Jun; 124(7):1915-25. PubMed ID: 12806624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
    Gabeta S; Norman GL; Liaskos C; Papamichalis PA; Zografos T; Garagounis A; Rigopoulou EI; Dalekos GN
    J Clin Immunol; 2007 Jul; 27(4):378-87. PubMed ID: 17514501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display.
    Ikuno N; Scealy M; Davies JM; Whittingham SF; Omagari K; Mackay IR; Rowley MJ
    Hepatology; 2001 Sep; 34(3):478-86. PubMed ID: 11526532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases.
    Terjung B; Spengler U
    Clin Rev Allergy Immunol; 2005 Apr; 28(2):115-33. PubMed ID: 15879618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?
    Muratori P; Muratori L; Gershwin ME; Czaja AJ; Pappas G; MacCariello S; Granito A; Cassani F; Loria P; Lenzi M; Bianchi FB
    Clin Exp Immunol; 2004 Jan; 135(1):154-8. PubMed ID: 14678277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis.
    Kadokawa Y; Omagari K; Hazama H; Ohba K; Masuda J; Kinoshita H; Hayashida K; Isomoto H; Mizuta Y; Murase K; Murata I; Kohno S
    Clin Biochem; 2003 May; 36(3):203-10. PubMed ID: 12726929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies against "nuclear dots" in primary biliary cirrhosis.
    Szostecki C; Guldner HH; Will H
    Semin Liver Dis; 1997 Feb; 17(1):71-8. PubMed ID: 9089912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of antimitochondrial antibodies in health adults.
    Mattalia A; Quaranta S; Leung PS; Bauducci M; Van de Water J; Calvo PL; Danielle F; Rizzetto M; Ansari A; Coppel RL; Rosina F; Gershwin ME
    Hepatology; 1998 Mar; 27(3):656-61. PubMed ID: 9500690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis.
    Tanaka A; Nezu S; Uegaki S; Mikami M; Okuyama S; Kawamura N; Aiso M; Gershwin ME; Takahashi S; Selmi C; Takikawa H
    Ann N Y Acad Sci; 2007 Jun; 1107():259-70. PubMed ID: 17804554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis?
    Butler P; Hamilton-Miller J; Baum H; Burroughs AK
    Biochem Mol Biol Int; 1995 Mar; 35(3):473-85. PubMed ID: 7773184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.